tiprankstipranks
Egetis Therapeutics AB (SE:EGTX)
FRANKFURT:EGTX
Sweden Market
EGTX
Egetis Therapeutics AB
RESEARCH TOOLSreports

Egetis Therapeutics AB (EGTX) Cash flow

― Followers

Egetis Therapeutics AB Cash Flow

SE:EGTX's free cash flow for Q4 2025 was kr-92.90M. For the 2025 fiscal year, SE:EGTX's free cash flow was decreased by kr-40.70M and operating cash flow was kr-92.90M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
kr -267.10Mkr -227.90Mkr -278.40Mkr -173.50Mkr -130.11M
Investing Cash Flow
kr -2.80Mkr -1.20Mkr -100.00Kkr -1.70Mkr -5.96M
Financing Cash Flow
kr 140.00Mkr 270.90Mkr 458.90Mkr 155.70Mkr -8.90M
End Cash Position
kr 215.80Mkr 351.00Mkr 303.30Mkr 127.70Mkr 143.97M
Free Cash Flow
kr -268.60Mkr -227.90Mkr -278.40Mkr -173.50Mkr -130.28M
Currency in SEK

Egetis Therapeutics AB Cash Flow